Assessment of Left Ventricular, Right Ventricular, and Left Atrial Strain in Light-Chain Amyloidosis

por Leedy, Douglas J., Vasbinder, Alexi, Huang, Hans D., Fernandes, Robin, Cowan, Andrew J., Gopal, Ajay K., Kirkpatrick, James N., Libby, Edward N., Cheng, Richard K.
Publicado 2020

Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study

por Trudel, Suzanne, Lendvai, Nikoletta, Popat, Rakesh, Voorhees, Peter M., Reeves, Brandi, Libby, Edward N., Richardson, Paul G., Hoos, Axel, Gupta, Ira, Bragulat, Veronique, He, Zangdong, Opalinska, Joanna B., Cohen, Adam D.
Publicado 2019

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

por Graf, Solomon A., Lynch, Ryan C., Ujjani, Chaitra S., Gooley, Ted A., Rasmussen, Heather, Coffey, David G., Cowan, Andrew J., Smith, Stephen D., Shadman, Mazyar, Warren, Edus H., Libby, Edward N., Greninger, Alexander L., Fromm, Jonathan R., Gopal, Ajay K.
Publicado 2022

Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial

por Gertz, Morie A., Cohen, Adam D., Comenzo, Raymond L., Kastritis, Efstathios, Landau, Heather J., Libby, Edward N., Liedtke, Michaela, Sanchorawala, Vaishali, Schönland, Stefan, Wechalekar, Ashutosh, Zonder, Jeffrey A., Palladini, Giovanni, Walling, Jackie, Guthrie, Spencer, Nie, Christie, Karp, Carol, Jin, Yuying, Kinney, Gene G., Merlini, Giampaolo
Publicado 2023

Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016

por Cowan, Andrew J., Allen, Christine, Barac, Aleksandra, Basaleem, Huda, Bensenor, Isabela, Curado, Maria Paula, Foreman, Kyle, Gupta, Rahul, Harvey, James, Hosgood, H. Dean, Jakovljevic, Mihajlo, Khader, Yousef, Linn, Shai, Lad, Deepesh, Mantovani, Lorenzo, Nong, Vuong Minh, Mokdad, Ali, Naghavi, Mohsen, Postma, Maarten, Roshandel, Gholamreza, Shackelford, Katya, Sisay, Mekonnen, Nguyen, Cuong Tat, Tran, Tung Thanh, Xuan, Bach Tran, Ukwaja, Kingsley Nnanna, Vollset, Stein Emil, Weiderpass, Elisabete, Libby, Edward N., Fitzmaurice, Christina
Publicado 2018

Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

por Morschhauser, Franck, Nastoupil, Loretta, Feugier, Pierre, Schiano de Colella, Jean-Marc, Tilly, Hervé, Palomba, Maria Lia, Bachy, Emmanuel, Fruchart, Christophe, Libby, Edward N., Casasnovas, Rene-Olivier, Flinn, Ian W., Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L., Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Le Gouill, Steven, Daguindau, Nicolas, Guidez, Stéphanie, Pica, Gian Matteo, García-Sancho, Alejandro Martín, López-Guillermo, Armondo, Larouche, Jean-François, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Kalung, Wu, Sehn, Laurie H., Izutsu, Koji, Cartron, Guillaume, Gkasiamis, Argyrios, Crowe, Russell, Xerri, Luc, Fowler, Nathan H., Salles, Gilles
Publicado 2022